| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051655275 |
| P356 | DOI | 10.1038/NRI2116 |
| P698 | PubMed publication ID | 17589542 |
| P5875 | ResearchGate publication ID | 6247017 |
| P50 | author | Dale I Godfrey | Q56957983 |
| P2093 | author name string | Stuart P Berzins | |
| P2860 | cites work | A distal effect of microsomal triglyceride transfer protein deficiency on the lysosomal recycling of CD1d | Q24676253 |
| Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2 | Q24685566 | ||
| CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides | Q28254991 | ||
| XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome | Q28271832 | ||
| The biology of NKT cells | Q28277482 | ||
| NKT cells derive from double-positive thymocytes that are positively selected by CD1d | Q28508188 | ||
| The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells | Q28512367 | ||
| GATA-3 regulates the development and function of invariant NKT cells | Q28590905 | ||
| Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. | Q32105308 | ||
| Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7 | Q33782527 | ||
| Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny | Q33935873 | ||
| Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size | Q33947957 | ||
| Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. | Q34053547 | ||
| Positive and negative selection of T cells | Q34157557 | ||
| Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain | Q34356372 | ||
| Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. | Q34597428 | ||
| Differential antitumor immunity mediated by NKT cell subsets in vivo | Q34603019 | ||
| A unique lymphotoxin {alpha}beta-dependent pathway regulates thymic emigration of V{alpha}14 invariant natural killer T cells | Q34694902 | ||
| Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency | Q34762274 | ||
| IL-15 availability conditions homeostasis of peripheral natural killer T cells | Q34807830 | ||
| Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals | Q35749602 | ||
| Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency | Q35749606 | ||
| Granulocyte-Macrophage Colony-Stimulating Factor Regulates Effector Differentiation of Invariant Natural Killer T Cells during Thymic Ontogeny | Q63363297 | ||
| A subset of CD4+ thymocytes selected by MHC class I molecules | Q72671900 | ||
| Lack of directed V alpha 14-J alpha 281 rearrangements in NK1+ T cells | Q73481251 | ||
| Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells | Q73496332 | ||
| Cutting edge: the Ets1 transcription factor is required for the development of NK T cells in mice | Q73520498 | ||
| Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors | Q73889862 | ||
| Homeostasis of V alpha 14i NKT cells | Q74817607 | ||
| IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation | Q77658417 | ||
| T Cell Development in Mice Expressing CD1d Directed by a Classical MHC Class II Promoter | Q79125440 | ||
| Expression of CD1d Under the Control of a MHC Class Ia Promoter Skews the Development of NKT Cells, But Not CD8+ T Cells | Q79125443 | ||
| Regulatory roles of NKT cells in the induction and maintenance of cyclophosphamide-induced tolerance | Q79401061 | ||
| Slamf1, the NKT cell control gene Nkt1 | Q79609724 | ||
| Cutting edge: impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein | Q79754919 | ||
| An alternate pathway for CD4 T cell development: thymocyte-expressed MHC class II selects a distinct T cell population | Q81354592 | ||
| Regulation of NKT cell development by SAP, the protein defective in XLP | Q81402277 | ||
| Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells | Q81512239 | ||
| Cutting edge: influence of the TCR Vbeta domain on the selection of semi-invariant NKT cells by endogenous ligands | Q82459119 | ||
| Analysis of the effect of different NKT cell subpopulations on the activation of CD4 and CD8 T cells, NK cells, and B cells | Q82857040 | ||
| Genetic and functional analysis of the Nkt1 locus using congenic NOD mice: improved Valpha14-NKT cell performance but failure to protect against type 1 diabetes | Q82984613 | ||
| DOCK2 is required in T cell precursors for development of Valpha14 NK T cells | Q83059294 | ||
| Comparative gene expression analysis of NKT cell subpopulations | Q83337497 | ||
| A thymic precursor to the NK T cell lineage | Q95783850 | ||
| T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells | Q35848548 | ||
| Going both ways: immune regulation via CD1d-dependent NKT cells | Q35951531 | ||
| Signaling for NKT cell development: the SAP-FynT connection | Q36076597 | ||
| Chewing the fat on natural killer T cell development. | Q36227953 | ||
| Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases | Q36227994 | ||
| A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition. | Q36228473 | ||
| The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells | Q36229257 | ||
| Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition | Q36238065 | ||
| MTP regulated by an alternate promoter is essential for NKT cell development | Q36267165 | ||
| Class I dependence of the development of CD4+ CD8- NK1.1+ thymocytes | Q36363308 | ||
| Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4-8- subsets of natural killer 1.1+ T cell receptor-alpha/beta+ cells in the liver of mice | Q36363483 | ||
| An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. | Q36363643 | ||
| Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes | Q36365532 | ||
| Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers | Q36368804 | ||
| A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage | Q36370202 | ||
| Distinct functional lineages of human V(alpha)24 natural killer T cells | Q36370354 | ||
| Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining | Q36370359 | ||
| CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells | Q36370736 | ||
| NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells | Q36370941 | ||
| The Src family tyrosine kinase Fyn regulates natural killer T cell development | Q36375458 | ||
| Lineage relationships and differentiation of natural killer (NK) T cells: intrathymic selection and interleukin (IL)-4 production in the absence of NKR-P1 and Ly49 molecules | Q36377137 | ||
| Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells | Q36380304 | ||
| Induction of differentiation of pre-NKT cells to mature Valpha14 NKT cells by granulocyte/macrophage colony-stimulating factor | Q36396689 | ||
| The cell surface receptor SLAM controls T cell and macrophage functions | Q36399495 | ||
| The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells | Q36400520 | ||
| Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product | Q36402758 | ||
| Characterization of the early stages of thymic NKT cell development | Q36402797 | ||
| Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes | Q36403175 | ||
| In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers | Q36404648 | ||
| Increased thymic B cells but maintenance of thymic structure, T cell differentiation and negative selection in lymphotoxin-alpha and TNF gene-targeted mice | Q36511394 | ||
| Requirement for membrane lymphotoxin in natural killer cell development. | Q37206961 | ||
| Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation | Q37358144 | ||
| Development of Valpha4+ NK T cells in the early stages of embryogenesis | Q37527374 | ||
| Testing the NKT cell hypothesis of human IDDM pathogenesis | Q39738424 | ||
| Thio-isoglobotrihexosylceramide, an agonist for activating invariant natural killer T cells. | Q40208296 | ||
| Lysosomal glycosphingolipid recognition by NKT cells | Q40493118 | ||
| CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses | Q40517634 | ||
| Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells | Q40600420 | ||
| The Paradox of Immune Molecular Recognition of α-Galactosylceramide: Low Affinity, Low Specificity for CD1d, High Affinity for αβ TCRs | Q40653197 | ||
| NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. | Q41719930 | ||
| The influence of CD1d in postselection NKT cell maturation and homeostasis | Q42483693 | ||
| Intrathymic NKT cell development is blocked by the presence of alpha-galactosylceramide | Q42601793 | ||
| An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells | Q42942523 | ||
| Differential requirement for Rel/nuclear factor kappa B family members in natural killer T cell development | Q42944908 | ||
| Negative selection in the thymus includes semimature T cells | Q42947706 | ||
| NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation | Q44113021 | ||
| Thymocyte expression of cathepsin L is essential for NKT cell development | Q44170965 | ||
| Lysosomal localization of murine CD1d mediated by AP-3 is necessary for NK T cell development | Q44608949 | ||
| Differential proliferative response of NKT cell subpopulations to in vitro stimulation in presence of different cytokines | Q44787834 | ||
| Restoration of NK T cell development in fyn-mutant mice by a TCR reveals a requirement for Fyn during early NK T cell ontogeny | Q44885062 | ||
| Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids | Q45050713 | ||
| Efficient activation of Valpha14 invariant NKT cells by foreign lipid antigen is associated with concurrent dendritic cell-specific self recognition | Q45214973 | ||
| Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors | Q46553571 | ||
| Distinct homeostatic requirements of CD4+ and CD4- subsets of Valpha24-invariant natural killer T cells in humans | Q46718817 | ||
| A cell-type specific CD1d expression program modulates invariant NKT cell development and function | Q46902170 | ||
| Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3). | Q46927341 | ||
| T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells | Q47765721 | ||
| Cutting edge: the ontogeny and function of Va14Ja18 natural T lymphocytes require signal processing by protein kinase C theta and NF-kappa B. | Q47810582 | ||
| NKT cells: what's in a name? | Q47895830 | ||
| Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections | Q50092191 | ||
| Sensitivity of NK1.1-negative NKT cells to transgenic BATF defines a role for activator protein-1 in the expansion and maturation of immature NKT cells in the thymus. | Q51998750 | ||
| Long-term retention of mature NK1.1+ NKT cells in the thymus. | Q52022963 | ||
| Development of CD1d-restricted NKT cells in the mouse thymus. | Q52085666 | ||
| Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes. | Q52119708 | ||
| Membrane lymphotoxin is required for the development of different subpopulations of NK T cells. | Q52167165 | ||
| CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells. | Q53565669 | ||
| NF-kappa B controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. | Q53644080 | ||
| Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice. | Q54626090 | ||
| Cutting Edge: Signaling Lymphocytic Activation Molecule-Associated Protein Controls NKT Cell Functions | Q58328314 | ||
| Thymic dependence of invariant Vα14+ Natural Killer-T cell development | Q58478772 | ||
| Limited correlation between human thymus and blood NKT?cell content revealed by an ontogeny study of paired tissue samples | Q60489505 | ||
| Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood: implications for human studies | Q60489534 | ||
| CD1d-Restricted NKT Cells: An Interstrain Comparison | Q62230429 | ||
| Three day neonatal thymectomy selectively depletes NK1.1+ T cells | Q62230521 | ||
| Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism | Q63259010 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 505-518 | |
| P577 | publication date | 2007-07-01 | |
| P1433 | published in | Nature Reviews Immunology | Q43355 |
| P1476 | title | Control points in NKT-cell development | |
| P478 | volume | 7 |
| Q37644961 | A double-edged sword: the role of NKT cells in malaria and HIV infection and immunity |
| Q38217703 | A prominent role for invariant T cells in the amphibian Xenopus laevis tadpoles |
| Q36892161 | Agonist-selected T cell development requires strong T cell receptor signaling and store-operated calcium entry. |
| Q43759628 | Alpha versus beta: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells? |
| Q34357987 | An essential role for the transcription factor HEB in thymocyte survival, Tcra rearrangement and the development of natural killer T cells |
| Q37003530 | Analyzing antigen recognition by Natural Killer T cells |
| Q37187358 | CD1d presentation of glycolipids |
| Q37207409 | CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences |
| Q36898124 | CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system |
| Q47906773 | CD28 controls the development of innate-like CD8+ T cells by promoting the functional maturation of NKT cells |
| Q36689593 | CDR3β sequence motifs regulate autoreactivity of human invariant NKT cell receptors. |
| Q36570136 | Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells. |
| Q43938466 | Clinical and genetic characteristics of XIAP deficiency in Japan |
| Q81635265 | Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells |
| Q37334414 | Combined deletion of Id2 and Id3 genes reveals multiple roles for E proteins in invariant NKT cell development and expansion |
| Q33947366 | Comparative analysis of activation phenotype, proliferation, and IFN-gamma production by spleen NK1.1(+) and NK1.1(-) T cells during Plasmodium chabaudi AS malaria |
| Q43152094 | Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76. |
| Q90860217 | Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin |
| Q33505805 | Control of CD56 expression and tumor cell cytotoxicity in human Vgamma2Vdelta2 T cells |
| Q37896127 | Control of early stages in invariant natural killer T-cell development. |
| Q35161504 | Coupling of T cell receptor specificity to natural killer T cell development by bivalent histone H3 methylation |
| Q55362848 | Critical Contribution of NK Group 2 Member D Expressed on Invariant Natural Killer T Cells in Concanavalin A-Induced Liver Hepatitis in Mice. |
| Q37018987 | Critical role of ROR-γt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. |
| Q37186461 | DOCK8 is critical for the survival and function of NKT cells |
| Q62230144 | Developing NKT cells need their (E) protein |
| Q51817697 | Developing NKT cells need their calcium. |
| Q45887234 | Development and maturation of invariant NKT cells in the presence of lysosomal engulfment |
| Q34510506 | Development of invariant natural killer T cells |
| Q34395749 | Developmental dynamics of post-selection thymic DN iNKT. |
| Q55117842 | Differential Role of Cathepsins S and B In Hepatic APC-Mediated NKT Cell Activation and Cytokine Secretion. |
| Q39953297 | Differential requirement for the SAP-Fyn interaction during NK T cell development and function |
| Q48261213 | Discrete TCR Binding Kinetics Control Invariant NKT Cell Selection and Central Priming. |
| Q51902274 | Distinct roles in NKT cell maturation and function for the different transcription factors in the classical NF-κB pathway. |
| Q36837547 | Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population |
| Q35195374 | Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids |
| Q27314724 | EBV promotes human CD8 NKT cell development |
| Q58655852 | Endogenous and Exogenous CD1-Binding Glycolipids |
| Q35767520 | Enzymatic synthesis of Gb3 and iGb3 ceramides. |
| Q35345626 | Essential role of Mediator subunit Med1 in invariant natural killer T-cell development |
| Q34527136 | Evolution of nonclassical MHC-dependent invariant T cells |
| Q44781663 | Frequencies of circulating IL-17-producing CD4+CD161+ T cells and CD4+CD161+ T cells correlate with disease activity in rheumatoid arthritis |
| Q24569631 | GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation |
| Q37154493 | Genetic control of murine invariant natural killer T cells maps to multiple type 1 diabetes regions |
| Q35795122 | Genetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type |
| Q35062758 | Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells |
| Q35597464 | Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C. |
| Q37349692 | Harnessing invariant NKT cells in vaccination strategies |
| Q33796925 | High-frequency and adaptive-like dynamics of human CD1 self-reactive T cells |
| Q37626290 | Homeostasis of IL-15 dependent lymphocyte subsets in the liver |
| Q24650966 | How do natural killer T cells help B cells? |
| Q51770932 | Human Th17 cells: are they different from murine Th17 cells? |
| Q42417394 | Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. |
| Q28741430 | IL-15 regulates homeostasis and terminal maturation of NKT cells |
| Q35801754 | IL-4 Induced Innate CD8+ T Cells Control Persistent Viral Infection. |
| Q30853609 | Identification of CD4(-)CD8(-) double-negative natural killer T cell precursors in the thymus |
| Q36617322 | Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology |
| Q36823884 | Impaired autophagy, defective T cell homeostasis, and a wasting syndrome in mice with a T cell-specific deletion of Vps34. |
| Q37322296 | Increased level of E protein activity during invariant NKT development promotes differentiation of invariant NKT2 and invariant NKT17 subsets |
| Q38075483 | Innate B cell helpers reveal novel types of antibody responses. |
| Q55337327 | Interactions Between the Neuroendocrine System and T Lymphocytes in Diabetes. |
| Q37196719 | Interactions between B-lymphocytes and type 1 NKT cells in autoimmune diabetes |
| Q36535354 | Interleukin-7 receptor controls development and maturation of late stages of thymocyte subpopulations. |
| Q37986831 | Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells |
| Q43992187 | Invariant NKT cell development and function in microRNA-223 knockout mice |
| Q35691274 | Invariant NKT cells require autophagy to coordinate proliferation and survival signals during differentiation |
| Q46076623 | Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells |
| Q60016776 | Invariant Natural Killer T Cells: Boon or Bane in Immunity to Intracellular Bacterial Infections? |
| Q36288508 | Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C. |
| Q38734173 | Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression. |
| Q37686081 | Invariant natural killer T cells in rheumatic disease: a joint dilemma |
| Q27673052 | Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria |
| Q34389948 | Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes |
| Q34323476 | Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions |
| Q36769825 | Ion channels in innate and adaptive immunity |
| Q37729205 | Loss of microRNAs in thymus perturbs invariant NKT cell development and function |
| Q33712435 | Lymphocytes in cancer development: polarization towards pro-tumor immunity |
| Q41820052 | MHC class II-expressing thymocytes suppress invariant NKT cell development |
| Q37913031 | MicroRNAs are key regulators controlling iNKT and regulatory T-cell development and function |
| Q50425147 | Murine CD8+ Invariant Natural Killer T Cells are Negatively Selected by CD1d Expressed on Thymic Epithelial Cells and Dendritic Cells |
| Q38172394 | NF-κB control of T cell development |
| Q37995690 | NF-κB subunit specificity in hemopoiesis. |
| Q37466352 | NK and NKT cells in aging and longevity: role of zinc and metallothioneins |
| Q62230249 | NKT cell development in the absence of the autoimmune regulator gene (Aire) |
| Q37545348 | NKT cells in mucosal immunity |
| Q37018981 | NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi |
| Q47221129 | Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective |
| Q39960222 | Natural Sphingomonas glycolipids vary greatly in their ability to activate natural killer T cells |
| Q38148759 | Natural killer T cell based Immunotherapy |
| Q37726701 | Natural killer T cells and atherosclerosis: form and function meet pathogenesis |
| Q38525797 | Natural killer T cells in liver injury, inflammation and cancer |
| Q51828144 | Natural killer T cells: drivers or passengers in preventing human disease? |
| Q40063602 | Newcastle disease virus mediates pancreatic tumor rejection via NK cell activation and prevents cancer relapse by prompting adaptive immunity. |
| Q86759354 | OCH-mediated shift of Th1 and Th2 cytokines by NKT cells in mice with aplastic anemia |
| Q38368925 | Orchestration of invariant natural killer T cell development by E and Id proteins |
| Q36922002 | Osteopontin regulates development and function of invariant natural killer T cells |
| Q36302397 | Pak2 Controls Acquisition of NKT Cell Fate by Regulating Expression of the Transcription Factors PLZF and Egr2. |
| Q37099863 | Peripheral NKT cells in simian immunodeficiency virus-infected macaques |
| Q63259008 | Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus |
| Q37599845 | Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response |
| Q41893247 | Polymorphisms in the CD1d promoter that regulate CD1d gene expression are associated with impaired NKT cell development |
| Q34160821 | Presumed guilty: natural killer T cell defects and human disease |
| Q36003420 | Promyelocytic leukemia zinc finger turns on the effector T cell program without requirement for agonist TCR signaling |
| Q45285840 | Ptpn11 Deletion in CD4+ Cells Does Not Affect T Cell Development and Functions but Causes Cartilage Tumors in a T Cell-Independent Manner |
| Q37688877 | Raising the NKT cell family |
| Q33878486 | Regulation of natural killer T-cell development by deubiquitinase CYLD |
| Q37834024 | Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis |
| Q46251286 | Rel/NF-kappaB family member RelA regulates NK1.1- to NK1.1+ transition as well as IL-15-induced expansion of NKT cells |
| Q37731978 | Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells |
| Q36648754 | Requirements for selection of conventional and innate T lymphocyte lineages |
| Q36946379 | Role of diacylglycerol kinases in T cell development and function |
| Q27023925 | Roles of TRAF3 in T cells: many surprises |
| Q33858298 | Runt-related transcription factor 3 is involved in the altered phenotype and function in ThPok-deficient invariant natural killer T cells |
| Q36079768 | SAP expression in invariant NKT cells is required for cognate help to support B-cell responses |
| Q36374279 | SAP is required for the development of innate phenotype in H2-M3--restricted Cd8(+) T cells |
| Q90383325 | SLAM-SAP-Fyn: Old Players with New Roles in iNKT Cell Development and Function |
| Q36456282 | Selection of self-reactive T cells in the thymus |
| Q37684417 | TIM-4 is expressed on invariant NKT cells but dispensable for their development and function |
| Q36907898 | TNF receptor associated factor 3 plays a key role in development and function of invariant natural killer T cells |
| Q38801811 | TRAF3 as a powerful and multitalented regulator of lymphocyte functions. |
| Q41855689 | TRAF3 enhances TCR signaling by regulating the inhibitors Csk and PTPN22. |
| Q34480227 | The DNA damage- and transcription-associated protein paxip1 controls thymocyte development and emigration. |
| Q58999398 | The Development of Unconventional Extrathymic Activated CD4+CD8+ T Cells in Chagas Disease |
| Q35739633 | The NF-κB1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties |
| Q33900265 | The Ras/MAPK pathway is required for generation of iNKT cells |
| Q36674728 | The Tec kinase ITK regulates thymic expansion, emigration, and maturation of γδ NKT cells |
| Q58620993 | The Transcription Factor Zfx Regulates Peripheral T Cell Self-Renewal and Proliferation |
| Q42068252 | The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function. |
| Q33563711 | The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferons |
| Q87944456 | The differential roles of mTOR, ERK, and JNK pathways in invariant natural killer T-cell function and survival |
| Q37310026 | The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells |
| Q42452487 | The making of NKT cells |
| Q38193865 | The potential role of iNKT cells in experimental allergic encephalitis and multiple sclerosis. |
| Q24648939 | The role of NKT cells in tumor immunity |
| Q41582338 | The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis |
| Q38090560 | The role of natural killer T cells in B cell malignancies |
| Q38224933 | The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells. |
| Q24654999 | The transcription factor PLZF directs the effector program of the NKT cell lineage |
| Q30434352 | The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage |
| Q48608874 | Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomas. |
| Q35662003 | Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality |
| Q37238805 | Tie2cre-induced inactivation of the miRNA-processing enzyme Dicer disrupts invariant NKT cell development |
| Q63362826 | Tissue-specific functions of invariant natural killer T cells |
| Q87943689 | Transcription factor YY1 is essential for iNKT cell development |
| Q34248566 | Transcriptional control of invariant NKT cell development |
| Q37695454 | Transcriptional regulation of NKT cell development and homeostasis |
| Q37429039 | Transcriptional regulator Id2 controls survival of hepatic NKT cells |
| Q41413030 | Translational control of NKT cell cytokine production by p38 MAPK. |
| Q37632469 | Translational mini-review series on Th17 cells: development of mouse and human T helper 17 cells. |
| Q38064849 | Type 2 innate lymphoid cells: friends or foes-role in airway allergic inflammation and asthma |
| Q37728011 | Type I natural killer T cells: naturally born for fighting |
| Q49574395 | Unraveling Natural Killer T-Cells Development |
| Q39325855 | Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs. |
| Q36448823 | ZBTB7B (Th-POK) regulates the development of IL-17-producing CD1d-restricted mouse NKT cells |
| Q33523809 | iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells |
| Q37857337 | iNKT cells in microbial immunity: recognition of microbial glycolipids. |
Search more.